|
Return to masthead | Disclosure
|
Neil R. Blacklow, MD, Editor-in-Chief
Dr. Blacklow has conducted extensive research on the etiology, pathogenesis, and diagnosis of viral gastroenteritis agents, most notably Norwalk virus, rotavirus, and astrovirus. The co-discoverer of adenovirus-associated viruses (AAV), he showed that these viruses infect humans. He has also directed an AIDS Clinical Trials Group center. He is the former Chair of Medicine at the University of Massachusetts Medical School and founding Director of its Division of Infectious Diseases. Dr. Blacklow has been editing and writing for
Journal Watch Infectious Diseases
since the publication was launched in 1998.
Return to masthead
| Disclosure
Richard T. Ellison III, MD, Deputy Editor
Dr. Ellison's research interests include nosocomial infections, HIV disease, infection control, and control and treatment of infections caused by antibiotic-resistant bacteria. He has pursued basic investigations into innate host defenses against bacterial pathogens and into novel antimicrobial agents active against antibiotic-resistant bacteria. A hospital epidemiologist, Dr. Ellison has focused his investigations on treating hospital-acquired infections and HIV disease. He is a past president of the Massachusetts Infectious Diseases Society. He has written for
Journal Watch Infectious Diseases
and served as Deputy Editor since the publication was launched in 1998.
Return to masthead
| Disclosure
Neil M. Ampel, MD, Associate Editor
Dr. Ampel's clinical interests include HIV infection and fungal infections, particularly coccidioidomycosis. His research focuses on the cellular immune response in coccidioidomycosis. He is a member of the NIH/CDC/IDSA Working Group for Therapy of Opportunistic Infections and the American Thoracic Society's Committee on the Treatment of Fungal Diseases Complicating AIDS. He is a former president of the Veterans' Administration Society for Practitioners of Infectious Diseases (VASPID). Dr. Ampel has been writing for
Journal Watch Infectious Diseases
since 2002.
Return to masthead
| Disclosure
Robert S. Baltimore, MD, Associate Editor
Dr. Baltimore's research has focused on group B streptococcus,
Pseudomonas aeruginosa, neonatal infections, and nosocomial infections. He is Co-Director of the Pediatric Tuberculosis Clinic and of the Training Program in Pediatric Infectious Diseases at Yale-New Haven Children's Hospital and is also a member of the Committee on Infectious Diseases of the American Academy of Pediatrics (the "Red Book" Committee). Dr. Baltimore has been writing for
Journal Watch Infectious Diseases
since the publication was launched in 1998.
Return to masthead
| Disclosure
Stephen G. Baum, MD, Associate Editor
Dr. Baum has conducted extensive research on DNA tumor viruses (adenovirus and SV40). A former president of the New York Society for Infectious Diseases, he has written chapters on adenovirus, mumps, asceptic meningitis, mycoplasma, and viral pneumonia for several textbooks. He currently serves on the New York City Department of Health and Mental Hygiene's Hospital Bioterrorism Advisory Subcommittee of the Weapons of Mass Destruction Advisory Group. Dr. Baum has been writing for
Journal Watch Infectious Diseases
since the publication was launched in 1998.
Return to masthead
| Disclosure
Bradley E. Britigan, MD, Associate Editor
Dr. Britigan's research interests focus on oxygen and iron metabolism of phagocytic cells and pathogenic organisms. His current research explores the nature of oxygen-centered free radicals essential to the microbicidal function of phagocytes, as well as the possible role of toxic free radicals in
Pseudomonas aeruginosa-induced tissue injury. He is past president of the American Federation for Medical Research. Dr. Britigan is currently the Chair of the Department of Internal Medicine at the University of Cincinnati College of Medicine. Prior to assuming that position in June 2004, he served as the Director of the Division of Infectious Diseases at the University of Iowa for the preceding 10 years. Dr. Britigan has been writing for
Journal Watch Infectious Diseases
since the publication was launched in 1998.
Return to masthead
| Disclosure
Thomas Glück, MD, Associate Editor
Dr. Glück is senior
lecturer in medicine and co-chief of the Division of Infectious Diseases,
Department of Medicine, University of Regensburg, Germany. He received his
specialty training in the U.S. and supports current efforts to establish
infectious diseases as a specialty in Germany. His research interests include
clinical sepsis, pathogenesis of sepsis, and infections in immunocompromised
patients. Dr. Glück has been writing for Journal Watch Infectious Diseases
since 2004.
Return to masthead | Disclosure
Roy M. Gulick, MD, MPH, Associate Editor
Dr. Gulick’s research interests include designing, conducting, and analyzing clinical trials to assess antiretroviral drugs with new mechanisms of action, refine antiretroviral therapy strategies, and test immune-based therapies in HIV infection. He is Director of the Cornell HIV Clinical Trials Unit, an investigator for the Columbia-Cornell AIDS Clinical Trials Unit, and Vice Chairman of the Treatment Strategies Research Agenda Committee of the AIDS Clinical Trials Group of the National Institutes of Health. He also serves on the Scientific Advisory Committee of the General Clinical Research Center at Weill-Cornell, is Co-Chairman of the Forum for Collaborative HIV Research, is a Board member of the International AIDS Society - U.S.A., and is a member of the Panel on Clinical Practices for Treatment of HIV Infection of the U.S. Department of Health and Human Services. He previously served as Chairman of the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration. Dr. Gulick has been writing for Journal Watch Infectious Diseases since 2005.
Return to masthead
Linda M. Mundy, MD, Associate Editor
Dr. Mundy's investigative career focuses on health outcomes, behaviors, and services at the intersection of infectious diseases and population health. Her current research interests include theory-based behavioral interventions to prevent the spread of transmissible agents and to optimize the treatment of conditions caused by these agents. Dr. Mundy is on the faculty at the School of Public Health of Saint Louis University and is a healthcare consultant to several national and international groups. She has been writing for
Journal Watch Infectious Diseases
since the publication was launched in 1998.
Return to masthead
| Disclosure
Mary E. Wilson, MD, Associate Editor
Dr. Wilson served as Chief of Infectious Diseases at Mount Auburn Hospital in Cambridge, Massachusetts, for more than 20 years. Her academic interests include tuberculosis, ecology of infections, emergence of new infections, determinants of disease distribution, travel medicine, and vaccines. She has served on the Advisory Committee for Immunization Practices of the CDC and the Academic Advisory Committee for the National Institute of Public Health in Mexico. Dr. Wilson has been writing for
Journal Watch Infectious Diseases
since the publication was launched in 1998.
Return to masthead
| Disclosure
|
|
 |
|
|
OUR OTHER EDITORIAL BOARDS
Journal Watch (General)
Journal Watch Cardiology
Journal Watch Dermatology
Journal Watch Emergency Medicine
Journal Watch Gastroenterology
Journal Watch Neurology
Journal Watch Pediatrics and Adolescent Medicine
Journal Watch Psychiatry
Journal Watch Women's Health
AIDS Clinical Care
|
Journal Watch
newsletters are owned, published, and
copyrighted
(©2006)